LEADER 05293nam 2200637 450 001 9910788287103321 005 20230120013037.0 035 $a(CKB)2670000000613632 035 $a(EBL)2038908 035 $a(SSID)ssj0001537799 035 $a(PQKBManifestationID)11827940 035 $a(PQKBTitleCode)TC0001537799 035 $a(PQKBWorkID)11525111 035 $a(PQKB)10921543 035 $a(Au-PeEL)EBL2038908 035 $a(CaPaEBR)ebr11050249 035 $a(CaONFJC)MIL778754 035 $a(OCoLC)910606246 035 $a(MiAaPQ)EBC2038908 035 $a(EXLCZ)992670000000613632 100 $a20150516h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aHealth of HIV infected people$hVolume I $efood, nutrition and lifestyle with antiretroviral drugs /$fedited by Ronald Ross Watson 210 1$aAmsterdam, [Netherlands] :$cAcademic Press,$d2015. 210 4$dİ2015 215 $a1 online resource (633 p.) 300 $aDescription based upon print version of record. 311 $a0-12-801143-2 311 $a0-12-800769-9 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aFront Cover; Health of HIV Infected People; Copyright Page; Contents; Preface; List of Contributors; Acknowledgement; I. Food and Overview; 1 Exercise and Rehabilitation; 1.1 Introduction; 1.2 Quality of Life; 1.3 Exercise and HAART; 1.3.1 Exercise Activities; 1.3.2 Rebound Exercise; 1.3.3 Studies with Rebound Exercise; 1.3.4 Precautions During Rebound Exercise; 1.3.5 Physiologic Responses Following Rebound Exercise; 1.3.6 Rebound Exercise and QoL; 1.4 Summary and Clinical Implications; References 327 $a2 Metabolic Abnormalities in HIV-Infected Populations without or with Antiretroviral Therapy (ART)2.1 Introduction; 2.1.1 Metabolic Abnormalities; 2.1.2 Grading of Severity in Dyslipidemia and Abnormal Glucose Level; 2.1.3 Anti-HIV Drugs by Class; 2.2 HIV-Associated Metabolic Abnormalities Without ART; 2.2.1 Pathophysiology of Serum Lipid Disorders; 2.2.2 Studies on Serum Lipid Disorders; 2.2.3 Serum Glucose Disorders; 2.2.4 Pathophysiology of Serum Glucose Disorders; 2.3 HIV-Associated Metabolic Abnormalities with ART; 2.3.1 Serum Lipid Disorders; 2.3.1.1 Epidemiology 327 $a2.3.2 Protease Inhibitors2.3.2.1 Mechanisms of PIs; 2.3.2.2 Dyslipidemia and PIs; 2.3.3 Nucleoside Reverse-Transcriptase Inhibitors; 2.3.3.1 Mechanism of NRTIs; 2.3.3.2 Dyslipidemia and NRTIs; 2.3.4 Non-nucleoside Reverse-Transcriptase Inhibitors; 2.3.4.1 Mechanism of NNRTIs; 2.3.4.2 Dyslipidemia and NNRTIs; 2.3.5 Dyslipidemia and Integrase Inhibitor and CCR Antagonist; 2.3.6 Glucose Metabolism; 2.3.6.1 Epidemiology; 2.3.6.2 Studies on Glucose Metabolism; 2.3.6.3 Mechanism of Antiretroviral Drugs on Glucose Metabolism; 2.4 Conclusion; References 327 $a3 Effects of Dietary Fat Intake on Acquired Immune Deficiency Syndrome During Antiretroviral Therapy3.1 Introduction; 3.1.1 Dietary Fat Intake in Health; 3.1.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome; 3.2 Dietary Fat Intake: A Role in HIV/AIDS; 3.3 Dietary Fat Intake and HIV/AIDS: Clinical Trials; 3.4 Conclusion; References; 4 Human Immunodeficiency Virus Infection-Associated Cancer and Mycotoxins in Food; 4.1 Epidemiology of Human Immunodeficiency Virus Infection; 4.2 Pathophysiology of HIV Infection with Immune Interference 327 $a4.3 Development of Cancer in a Patient with HIV4.4 Patients with HIV and ADCs; 4.5 HIV-Infected Patients with NADCs; 4.6 Mycotoxins in Patients with HIV; References; 5 Effects of Omega-3 Fatty Acids on Body Composition and Health in HIV/AIDS During HAART Therapy; 5.1 Introduction; 5.2 Signs and Symptoms; 5.3 Transmission; 5.4 Correlation of Dietary Fats and HIV; 5.5 Diagnosis and Treatment; 5.6 Antiretroviral Therapy; 5.7 Glucose Tolerance Overview; 5.8 Saturated Fatty Acids and HIV/AIDS; 5.9 Unsaturated Fatty Acids and HIV/AIDS; 5.10 Omega-3 Fatty Acids and HIV/AIDS 327 $a5.11 HIV/AIDS and Dietary Fat Supplementation 330 $a Health of HIV Infected People: Food, Nutrition and Lifestyle with Antiretroviral Drugs provides basic and applied knowledge on the supportive roles of bioactive foods, exercise, and dietary supplements on HIV/AIDS patients receiving antiretroviral drugs. Approaches include the application of traditional herbs and foods aiming to define both the risks and benefits of such practices. Readers will learn how to treat or ameliorate the effects of chronic retroviral disease using readily available, cheap foods, dietary supplements, and lifestyle changes with specific attention to the needs of pa 606 $aHIV-positive persons$xHealth and hygiene 606 $aAIDS (Disease)$xTreatment 606 $aAntiretroviral agents 615 0$aHIV-positive persons$xHealth and hygiene. 615 0$aAIDS (Disease)$xTreatment. 615 0$aAntiretroviral agents. 676 $a616.979206 702 $aWatson$b Ronald R$g(Ronald Ross), 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910788287103321 996 $aHealth of HIV infected people$93711836 997 $aUNINA